These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34011777)

  • 1. [MANAGEMENT, DIAGNOSIS, AND TREATMENT OF SEVERE ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS TO COVID-19 VACCINE].
    Asano K; Fujisawa T; Nakamura Y; Nagata M; Hide M; Fujieda S
    Arerugi; 2021; 70(3):215-223. PubMed ID: 34011777
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaphylaxis is a rare reaction in COVID-19 vaccination.
    Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
    J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Klimek L; Chaker AM; Cuevas M
    Laryngorhinootologie; 2021 May; 100(5):344-354. PubMed ID: 33684947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients at risk of anaphylaxis after COVID 19 vaccination.
    Gangemi S; Allegra A; Di Gioacchino M
    J Biol Regul Homeost Agents; 2021; 35(3):843-846. PubMed ID: 34231348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?".
    Cabanillas B; Akdis CA; Novak N
    Allergy; 2021 Jun; 76(6):1938-1940. PubMed ID: 34128561
    [No Abstract]   [Full Text] [Related]  

  • 6. ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper.
    Klimek L; Jutel M; Akdis CA; Bousquet J; Akdis M; Torres MJ; Agache I; Canonica GW; Del Giacco S; O'Mahony L; Shamji MH; Schwarze J; Untersmayr E; Ring J; Bedbrook A; Worm M; Zuberbier T; Knol E; Hoffmann-Sommergruber K; Chivato T
    Allergy; 2021 Jun; 76(6):1624-1628. PubMed ID: 33378789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of anaphylaxis due to COVID-19 vaccines in the elderly.
    Bousquet J; Agache I; Blain H; Jutel M; Ventura MT; Worm M; Del Giacco S; Benetos A; Bilo BM; Czarlewski W; Abdul Latiff AH; Al-Ahmad M; Angier E; Annesi-Maesano I; Atanaskovic-Markovic M; Bachert C; Barbaud A; Bedbrook A; Bennoor KS; Berghea EC; Bindslev-Jensen C; Bonini S; Bosnic-Anticevich S; Brockow K; Brussino L; Camargos P; Canonica GW; Cardona V; Carreiro-Martins P; Carriazo A; Casale T; Caubet JC; Cecchi L; Cherubini A; Christoff G; Chu DK; Cruz AA; Dokic D; El-Gamal Y; Ebisawa M; Eberlein B; Farrell J; Fernandez-Rivas M; Fokkens WJ; Fonseca JA; Gao Y; Gavazzi G; Gawlik R; Gelincik A; Gemicioğlu B; Gotua M; Guérin O; Haahtela T; Hoffmann-Sommergruber K; Hoffmann HJ; Hofmann M; Hrubisko M; Illario M; Irani C; Ispayeva Z; Ivancevich JC; Julge K; Kaidashev I; Khaitov M; Knol E; Kraxner H; Kuna P; Kvedariene V; Lauerma A; Le LTT; Le Moing V; Levin M; Louis R; Lourenco O; Mahler V; Martin FC; Matucci A; Milenkovic B; Miot S; Montella E; Morais-Almeida M; Mortz CG; Mullol J; Namazova-Baranova L; Neffen H; Nekam K; Niedoszytko M; Odemyr M; O'Hehir RE; Okamoto Y; Ollert M; Palomares O; Papadopoulos NG; Panzner P; Passalacqua G; Patella V; Petrovic M; Pfaar O; Pham-Thi N; Plavec D; Popov TA; Recto MT; Regateiro FS; Reynes J; Roller-Winsberger RE; Rolland Y; Romano A; Rondon C; Rottem M; Rouadi PW; Salles N; Samolinski B; Santos AF; S Sarquis F; Sastre J; M G A Schols J; Scichilone N; Sediva A; Shamji MH; Sheikh A; Skypala I; Smolinska S; Sokolowska M; Sousa-Pinto B; Sova M; Stelmach R; Sturm G; Suppli Ulrik C; Todo-Bom AM; Toppila-Salmi S; Tsiligianni I; Torres M; Untersmayr E; Urrutia Pereira M; Valiulis A; Vitte J; Vultaggio A; Wallace D; Walusiak-Skorupa J; Wang DY; Waserman S; Yorgancioglu A; Yusuf OM; Zernotti M; Zidarn M; Chivato T; Akdis CA; Zuberbier T; Klimek L
    Allergy; 2021 Oct; 76(10):2952-2964. PubMed ID: 33811358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.
    Yacoub MR; Cucca V; Asperti C; Ramirez GA; Della-Torre E; Moro M; Zandalasini C; Di Napoli D; Ambrosio A; Signorelli C; Colombo S; Beretta L; Ciceri F; Zangrillo A; Dagna L
    Vaccine; 2021 Oct; 39(44):6464-6469. PubMed ID: 34598820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World.
    Greenhawt M; Abrams EM; Oppenheimer J; Vander Leek TK; Mack DP; Singer AG; Shaker M
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1438-1441. PubMed ID: 33529722
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.
    Ring J; Worm M; Wollenberg A; Thyssen JP; Jakob T; Klimek L; Bangert C; Barbarot S; Bieber T; de Bruin-Weller MS; Chernyshov PV; Christen-Zaech S; Cork M; Darsow U; Flohr C; Fölster-Holst R; Gelmetti C; Gieler U; Gutermuth J; Heratizadeh A; Hijnen DJ; von Kobyletzki LB; Kunz B; Paul C; De Raeve L; Seneschal J; Simon D; Spuls PI; Stalder JF; Svensson A; Szalai Z; Taieb A; Torrelo A; Trzeciak M; Vestergaard C; Werfel T; Weidinger S; Deleuran M
    J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):e362-e365. PubMed ID: 33752263
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
    Peter J
    S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
    Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine anaphylaxis: PEG or not?
    Krantz MS; Liu Y; Phillips EJ; Stone CA
    Allergy; 2021 Jun; 76(6):1934-1937. PubMed ID: 34128562
    [No Abstract]   [Full Text] [Related]  

  • 14. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
    Moghimi SM
    Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
    [No Abstract]   [Full Text] [Related]  

  • 15. The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis.
    Shaker M; Phillips E; Blumenthal KG; Abrams EM; Banerji A; Oppenheimer J; Vander Leek TK; Mack DP; Wickner PG; Singer AG; Khan DA; Greenhawt M
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2556-2561. PubMed ID: 33892171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
    Murphy KR; Patel NC; Ein D; Hudelson M; Kodoth S; Marshall GD; Parikh P; Blaiss MS
    Ann Allergy Asthma Immunol; 2021 Apr; 126(4):319-320. PubMed ID: 33493641
    [No Abstract]   [Full Text] [Related]  

  • 17. Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
    Cabanillas B; Akdis CA; Novak N
    Allergy; 2021 Jun; 76(6):1617-1618. PubMed ID: 33320974
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
    Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful administration of second dose of BNT162b2 COVID-19 vaccine in two patients with potential anaphylaxis to first dose.
    Cahill JA; Kan M
    Allergy; 2022 Jan; 77(1):337-338. PubMed ID: 34965310
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.